NutraLife BioSciences, Inc. (NLBS)

USD 0.0

(0.0%)

Market Cap (In USD)

17.66 Thousand

Revenue (In USD)

-

Net Income (In USD)

-

Avg. Volume

801.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-3.0E-4
PE
-
EPS
-
Beta Value
-15.206
ISIN
US67098B1070
CUSIP
67098B107
CIK
1563463
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Edgar Ward
Employee Count
-
Website
https://www.nutralifebiosciences.com
Ipo Date
2014-05-28
Details
NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol (CBD) products. Its CBD products include cannabinoid-rich hemp oil derived from industrial hemp; tinctures; topical lotions and oils applied directly to the skin to treat pain or inflammation; face creams; massage oils; nutraceutical sprays with CBD as an added ingredient; and pet products. The company also offers other products, such as skincare and sanitizer products. NutraLife BioSciences, Inc. sells its products through nutralifebiosciences.com, as well as through private label distributors, online retailers, and retail outlets. The company was formerly known as NutraFuels, Inc. and changed its name to NutraLife BioSciences, Inc. in March 2019. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida.